Sales and Marketing
Gilead acquires immuno-oncology firm Forty Seven in $4.9 billion deal
March 3, 2020 Manufacturing and Production, Sales and Marketing Cancer, Forty Seven, Gilead, acquisition, oncology, pharma
Sanofi scores FDA approval for Sarclisa combo in relapsed, refractory multiple myeloma
March 3, 2020 Manufacturing and Production, Sales and Marketing Cancer, Sanofi, Sarclisa, multiple myeloma, pharma
Funding overview for the pharmaceutical industry and outlook for 2020
March 2, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2020, M&A, MA, feature, mergers & acquisitions, opinion, pharma
GW Pharma takes back control of UK Sativex sales from Bayer
March 2, 2020 Sales and Marketing Bayer, GW Pharma, Sativex, UK
UK Health Secretary says no tactics will be “off the table” in dealing with coronavirus
March 2, 2020 Sales and Marketing Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus
FDA approves first generic version of Shkreli-hiked toxoplasmosis drug Daraprim
March 2, 2020 Sales and Marketing Cerovene, Daraprim, FDA, Martin Shkreli, generics, pharma
Sanofi set to pay $11.9 million to resolve kickback probe, US Justice Department announces
March 2, 2020 Sales and Marketing Co pays, Justice department, Medicaid, Medicare, Sanofi, insurance
Experimental drug could treat dyskinesia in people with Parkinson’s
March 2, 2020 Sales and Marketing Parkinson's, Parkinson's disease, dyskinesia, spasms
Takeda’s subcutaneous vedolizumab nabs CHMP nod for maintenance of ulcerative colitis and Crohn’s
February 28, 2020 Medical Communications, Sales and Marketing CHMP, EMA, Takeda, vedolizumab
Top Ten most popular articles on Pharmafile.com this week
February 28, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Johnson and Johnson, Wuhan Coronavirus, coronavirus
Acacia Pharma secures first FDA approval with Barhemsys for postoperative nausea and vomiting
February 28, 2020 Medical Communications, Sales and Marketing Acacia, FDA, UK, US, pharma
The March 2020 issue of Pharmafocus is available to read free online now!
February 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing England, Pharmafocus, UK, mumps, pharma, pharmacovigilance, type 2 diabetes
FDA advisory committee narrowly backs Eli Lilly’s Cyramza combo for metastatic EGFR+ NSCLC
February 27, 2020 Sales and Marketing Eli Lilly, FDA, cyramza, pharms
NICE recommends Celgene’s Revlimid combo for follicular lymphoma
February 27, 2020 Sales and Marketing Cancer, Celgene, NICE, Revlimid, follicular lymphoma, pharma
NICE rejects Roche’s Polivy combo in relapsed or refractory diffuse large B-cell lymphoma
February 26, 2020 Manufacturing and Production, Research and Development, Sales and Marketing NHS, NICE, Polivy, Roche
Latest content
Recruitment experts hired in search for new CGT Catapult chief
Envirogen secures place on NHS Scotland reverse osmosis framework
